Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zyanya L. Zatarain‐Barrón
Immunotherapy at Any Line of Treatment Improves Survival in Patients With Advanced Metastatic Non‐small Cell Lung Cancer (NSCLC) Compared With Chemotherapy (Quijote‐CLICaP)
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Related publications
Immunotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Maintenance Therapy Improves Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Lung
Pulmonary
Respiratory Medicine
Treatment Results Including More Than Third-Line Chemotherapy for Patients With Advanced Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Pcn148 - Cost-Effectiveness Analysis of Atezolizumab Compared to Treatment Options for Adult Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Nsclc) After Prior Chemotherapy - Updated Results
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Predictive Factors Associated With Prolonged Survival in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated With Gefitinib
British Journal of Cancer
Cancer Research
Oncology
First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
P1.01-53 Bone Metastases and Efficacy of Immunotherapy in Patients With Pretreated Advanced Non-Small-Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Meta-Analysis of EGFR Tyrosine Kinase Inhibitors Compared With Chemotherapy as Second-Line Treatment in Pretreated Advanced Non-Small Cell Lung Cancer
PLoS ONE
Multidisciplinary
Correlation of BRCA1, TXR1 and TSP1 mRNA Expression With Treatment Outcome to Docetaxel-Based First-Line Chemotherapy in Patients With Advanced/Metastatic Non-Small-Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
